Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Gut and Liver ; : 607-614, 2015.
Article Dans Anglais | WPRIM | ID: wpr-216110

Résumé

BACKGROUND/AIMS: Proton pump inhibitors (PPIs) act by irreversibly binding to the H+-K+-ATPase of the proton pump in parietal cells and may possibly affect the vacuolar H+-ATPase in osteoclasts. METHODS: We investigated the effect of 8 weeks of PPI treatment on the parameters of bone turnover and compared PPI with revaprazan, which acts by reversibly binding to H+-K+-ATPase in proton pumps. This study was a parallel randomized controlled trial. For 8 weeks, either a PPI or revaprazan was randomly assigned to patients with gastric ulcers. The parameters of bone turnover were measured at the beginning of and after the 8-week treatment period. RESULTS: Twenty-six patients (PPI, n=13; revaprazan, n=13) completed the intention-to-treat analysis. After the 8-week treatment period, serum calcium and urine deoxypyridinoline (DPD) were increased in the PPI group (serum calcium, p=0.046; urine DPD, p=0.046) but not in the revaprazan group. According to multivariate linear regression analysis, age > or =60 years was an independent predictor for the changes in serum calcium and urine DPD. CONCLUSIONS: In elderly patients, administering a PPI for 8 weeks altered bone parameters. Our study suggested that PPIs might directly alter bone metabolism via the vacuolar H+-ATPase in osteoclasts.


Sujets)
Sujet âgé , Femelle , Humains , Mâle , Adulte d'âge moyen , Acides aminés/effets des médicaments et des substances chimiques , Remodelage osseux/effets des médicaments et des substances chimiques , Os et tissu osseux/métabolisme , Calcium/sang , Analyse en intention de traitement , Modèles linéaires , Analyse multifactorielle , Ostéoclastes/métabolisme , Études prospectives , Inhibiteurs de la pompe à protons/pharmacologie , Pyrimidinones/pharmacologie , Tétrahydroisoquinoléines/pharmacologie
2.
Korean Journal of Medicine ; : 449-454, 2014.
Article Dans Anglais | WPRIM | ID: wpr-176494

Résumé

Spontaneous arterial bleeding has been reported rarely. In a patient consuming heavy amounts of alcohol with alcoholic liver cirrhosis, spontaneous bleeding can be evoked by thrombocytopenia, altered platelet function, and shear stress on fully dilated arteries by portal hypertension. Alcohol consumption itself can also predispose a patient to bleeding by influencing the aggregation and activation of platelets, and altering the coagulation and fibrinolysis pathway. All of these mechanisms could cause patients with alcoholic liver cirrhosis to bleed spontaneously; however, conditions inducing peripheral arterial bleeding are very rare. Here, we report three cases of spontaneous arterial bleeding in patients with liver cirrhosis consuming heavy amounts of alcohol. All of the patients bled without any physical trauma, and the involved arteries were the intercostal arteries in two cases and a gastroduodenal artery in the other case. The patients were treated by angiographic embolization. One expired due to recurrence of arterial bleeding despite repeated angiographic embolization and massive transfusion.


Sujets)
Humains , Consommation d'alcool , Artères , Plaquettes , Embolisation thérapeutique , Fibrinolyse , Hémorragie , Hypertension portale , Cirrhose du foie , Cirrhose alcoolique , Récidive , Thrombopénie
SÉLECTION CITATIONS
Détails de la recherche